COGNITIVE IMPAIRMENT IN THE ELDERLY AT FAMILY CASES OF ATHEROSCLEROSIS-ASSOCIATED DISEASES
https://doi.org/10.15372/ATER20190206
Abstract
The assessment of the cognitive testing success in the elderly (by the Mini-Cog test) depending on the presence of a burdened family anamnesis by stroke and dementia in the parents of the examined persons has been performed. 305 people were examined (participants of the health groups in the Regional Gerontological Center – continuous series): 31 (10.2 %) men and 274 (89.8 %) women. The average age of men was 71.4 ± 7.2 years, women – 67.4 ± 7.6 years. It was shown that the burdened family anamnesis by atherosclerosis-associated diseases (stroke and dementia) has a negative impact on the state of cognitive functions in the elderly.
About the Author
A. V. Sukhanov
НИИ терапии и профилактической медицины – филиал ФГБНУ ФИЦ Институт цитологии и генетики СО РАН
Russian Federation
Russian Federation
References
1. Яхно Н.Н., Захаров В.В. Деменции. М.: Медпресс-информ, 2011. 272 с.
2. Fratiglioni L., Launer L.J., Andersen K. et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group // Neurology. 2000. Vol. 54 (11 Suppl 5). P. S10–S15.
3. Левин О.С., Трусова Н.А. Сосудистые факторы риска болезни Альцгеймера // Журн. неврологии и психиатрии им. Корсакова. 2013. Т. 113, ¹ 7. С. 3–12.
4. Schneider J.A., Bennett D.A. Where vascular meets neurodegenerative disease // Stroke. 2010. Vol. 41 (10 Suppl). P. S144–S146.
5. Schneider J.A. High blood pressure and microinfarcts: a link between vascular risk factors, dementia, and clinical Alzheimer’s disease // J. Am. Geriatr. Soc. 2009. Nov. Vol. 57, N 11. P. 2146–2147. doi: 10.1111/j.1532-5415.2009.02521.x.
6. Ritter A., Pillai J.A. Treatment of vascular cognitive impairment // Curr Treat. Options Neurol. 2015. Aug; Vol. 17, N 8. P. 367. doi: 10.1007/s11940-015-0367-0.
7. Дзизинский А.А., Пузырев В.П. Наследственность и атеросклероз. М.: Наука, 1977. 176 с.
8. Мясников А.Л. Гипертоническая болезнь и атеросклероз. М.: Медицина, 1965. 615 с.
9. McCarron M.O., Delong D., Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis // Neurology. 1999. Vol. 53, N 6. P. 1308–1308.
10. Voevoda M.I., ustinov S.N., Yudin N.S. et al. Association of the CCR2 chemokine receptor gene polymorphism with myocardial infarction // Dokl. Biol. Sci. 2002. Vol. 385, N 1-6. P. 367–370.
11. Суханов А.В., Диптан А.В., Качалова Г.А., Шураева Г.А. Метаболический синдром – фактор риска когнитивных нарушений у пожилых участников групп здоровья // Успехи геронтологии. 2018. Т. 31, ¹ 3. С. 423–427.
12. Дамулин И.В. Когнитивные расстройства сосудистого генеза: патогенетические, клинические и терапевтические аспекты // Нервные болезни. 2012. ¹ 4. С. 14–20.
Review
For citations:
Sukhanov A.V. COGNITIVE IMPAIRMENT IN THE ELDERLY AT FAMILY CASES OF ATHEROSCLEROSIS-ASSOCIATED DISEASES. Ateroscleroz. 2019;15(2):39-44. (In Russ.) https://doi.org/10.15372/ATER20190206
Views:
292
Email this article 